In April 2018 PharmaVision Europe launches on key markets in Europe and in Central Asia new patented formula for Urinary Health – UROPROST tabl. x 60.
The product is intended for peroral immunotherapy of acute or chronic non-specific infections of the urinary tract in children and adults.
UROPROST has excellent tolerance and no contraindications. The therapy can be combined with antibiotics.
Photos and information from the scientific launch events will follow.
